Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule

Publications

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

2003

Ahonen, T. J., J. Xie, M. J. LeBaron, J. Zhu, M. Nurmi, K. Alanen, H. Rui, and M. T. Nevalainen. 2003. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. J Biol Chem 278:27287-27292.

Albanese, C., K. Wu, M. D'Amico, F. Attiga, D. Joyce, J. Hughes, J. Hulit, T. Sakamaki, M. Fu, A. Ben-Ze'ev, J. F. Bromberg, C. Lamberti, K.-M. Lin, R. B. Gaynor, S. W. Byers, and R. G. Pestell. 2003. IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol.Biol.Cell 14:585-599.

Amri, H., K. Drieu, and V. Papadopoulos. 2003. Transcriptional suppression of the adrenal cortical peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by ginkgolide B. Biochem.Pharmacol. 65:717-729.

Anway, M. D., Y. Li, N. Ravindranath, M. Dym, and M. D. Griswold. 2003. Expression of testicular germ cell genes by differential display analysis. J.Androl. 24:173-184.

Atlas, E., M. Cardillo, I. Mehmi, H. Zahedkargaran, C. Tang, and R. Lupu. 2003. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. Mol.Cancer Res. 1:165-175.

Bachis, A., E. O. Major, and I. Mocchetti. 2003. Brain-derived neurotrophic factor inhibits HIV-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J.Neurosci. 23:5715-5722.

Benitah, S. A., P. F. Valeron, H. Rui, and J. C. Lacal. 2003. STAT5a Activation Mediates the Epithelial to Mesenchymal Transition Induced by Oncogenic RhoA. Mol.Biol.Cell 14:40-53.

Cai, D., A. Iyer, K. N. Felekkis, R. I. Near, Z. Luo, J. Chernoff, C. Albanese, R. G. Pestell, and A. Lerner. 2003. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res. 63:6802-6808.

Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR. 2003. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res 63(23):8097-8102.

Giatzakis, C. and V. Papadopoulos. 2003. Differential Utilization of the Promoter of Peripheral-Type Benzodiazepine Receptor by Steroidogenic Versus Non-steroidogenic Cell Lines and the Role of Sp1 and Sp3 in the Regulation of Basal Activity. Endocrinology. 145(3):1113-23.

D'Amico, M., K. Wu, D. Di Vizio, A. T. Reutens, M. Stahl, M. Fu, C. Albanese, R. G. Russell, W. J. Muller, M. White, A. Negassa, H. W. Lee, R. A. DePinho, and R. G. Pestell. 2003. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. Cancer Res 63:3395-3402.

Espinoza, L. A. and M. E. Smulson. 2003. Macroarray Analysis of the Effects of JP-8 Jet Fuel on Gene Expression in Jurkat Cells. Toxicology 189:181-190.

Fu, M., M. Rao, C. Wang, T. Sakamaki, J. Wang, D. Di Vizio, X. Zhang, C. Albanese, S. Balk, C. Chang, S. Fan, E. Rosen, J. J. Palvimo, O. A. Janne, S. Muratoglu, M. L. Avantaggiati, and R. P. Pestell. 2003. Acetylation of Androgen Receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol.Cell.Biol 23:8563-8575.

Gober, M., C. C. Smith, K. Ueda, J. A. Toretsky, and L. Aurelian. 2003. Forced expression of the H11 heat shock protein can be regulated by DNA methylation and trigger apoptosis in human cells. J.Biol.Chem. Sep 26;278(39):37600-37609.

Hu, Y.-L., C. Albanese, R. G. Pestell, and R. B. Jaff. 2003. Dual Mechanisms for Lysophosphatidic Acid Stimulation of Human Ovarian Carcinoma Cells. J.Natl.Cancer Inst. 95:733-740.

Iyengar, P., T. P. Combs, S. J. Shah, V. Gouon-Evans, J. W. Pollard, C. Albanese, L. Flanagan, M. P. Tenniswood, C. Guha, M. P. Lisanti, R. G. Pestell, and P. E. Scherer. 2003. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of antiapoptotic transcriptional programs and protooncogene stabilization. Oncogene 22:6408-6423.

Kagan, B. L., R. T. Henke, R. Cabal-Manzano, G. E. Stoica, Q. Nguyen, A. Wellstein, and A. T. Riegel. 2003. Complex regulation of the fibroblast growth factor binding protein (FGF-BP) in MDA MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res. 63:1696-1705.

Kimura, K., M. Markowski, L. Edsall, S. Spiegel, and E. P. Gelmann. 2003. Role of ceramide in mediating apoptosis in irradiated LNCaP prostate cancer cells. Cell Death.Diff. 10:240-248.

Lee, C. and T. Waldman. 2003. Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341. Cancer Biol Ther. 2:700-701.

Luo, X. Y., X. Q. Gong, and C. K. Tang. 2003. Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme. Int.J.Cancer 104:716-721.

Martin, M. B., R. Reiter, T. Pham, Y. R. Avellanet, J. Camara, M. Lahm, E. Pentecost, K. Pratap, B. A. Gilmore, S. Divekar, R. S. Dagata, J. L. Bull, and A. Stoica. 2003. Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 144:2425-2436.

Mateo-Lozano, S., O. M. Tirado, and V. Notario. 2003. Rapamycin induces the fusion-type independent down-regulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation. Oncogene 22:9281-9286.

Neimeister, P., F. Pixley, Y. Xiong, H. Xie, K. Wu, A. Ashton, M. Cammer, A. Chan, M. Symons, E. R. Stanley, and R. G. Pestell. 2003. Cyclin D1 governs adhesion and motility of Macrophages. Mol.Cell.Biol. 14:2005-2015.

Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY. 2003. Characterization of matriptase expression in normal human tissues. J Histochem Cytochem. 51(8):1017-1025.

Oberst, M. D., C. A. Williams, R. B. Dickson, M. D. Johnson, and C. Y. Lin. 2003. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem. 278:26773-26779.

Pengetzne, Y., M. S. Steed, K. R. Roby, P. F. Terranova, and C. C. Taylor. 2003. Src tyrosine kinase promotes survival and resistance to chemotheraputics in a mouse ovarian cancer cell line. Biochem.Biophys.Res.Commun. 309:377-383.

Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD. (2003). Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics.13(8):501-507.

Rait, A., K. F. Pirollo, D. Ulick, K. J. Cullen, and E. H. Chang. 2003. Her-2 Targeted Antisense Oligonucleotides Result in Sensitization of Head and Neck Cancer Cells to chemotherapeutic Agent. Ann.N.Y.Acad.Sci. 1002:1-12.

Ramljak, D., C. M. Coticchia, T. G. Nishanian, M. Saji, M. D. Ringel, S. D. Conzen, and R. B. Dickson. 2003. Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells. Exp.Cell Res 287:397-410.

Ray, R., R. Cabal-Manzano, A. R. Moser, R. Waldman, L. M. Zipper, A. Aigner, S. W. Byer, A. T. Reigel, and A. Wellstein. 2003. Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis. Cancer Res. 63:8085-8089.

Rosenthal, D. S., A. Velena, F. P. Chou, R. Schlegel, R. Ray, B. Benton, D. Anderson, W. J. Smith, and C. M. Simbulan-Rosenthal. 2003. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J.Biol.Chem. 278:8531-8540.

Rudin, C. M., Z. Yang, L. M. Schumaker, D. J. VanderWeele, K. Newkirk, M. J. Egorin, E. G. Zuhowski, and K. J. Cullen. 2003. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res. 63:312-318.

Sanchez R, Franco A, Gacto M, Notario V, Cansado J. Characterization of gdp1+ as encoding a GDPase in the fission yeast Schizosaccharomyces pombe. 2003. FEMS Microbiol Lett 228(1):33-38.

Shah, S., A. Hecht, R. Pestell, and S. W. Byers. 2003. Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem 278:48137-48145.

Sheen, J. H., J. K. Woo, and R. B. Dickson. 2003. c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells. Br J Cancer 89:1479-1485.

Simbulan-Rosenthal, C., D. S. Rosenthal, R. Luo, R. Samara, L. A. Espinoza, P. O. Hassa, M. O. Hottiger, and M. E. Smulson. 2003. PARP-1 Binds E2F-l Independently of its DNA Binding and Catalytic Domains, and Acts as a Novel Co Activator of E2F-1Mediated Transcription During Reentry of Quiescent Cells into S-phase. Oncogene 22:8460-8471.

Song, D.H., Rana, B., J. R. Wolfe, G. Crimmins, C. Choi, C. Albanese, T. C. Wang, R. G. Pestell, and M. M. Wolfe. 2003. Gastrin Induced Gastric Adenocarcinoma growth is mediated through Cyclin D1. Amer.J.Physio.GI Liver Physio. 285(1):G217-222.

Song, L. N., R. Herrell, S. Byers, S. Shah, E. M. Wilson, and E. P. Gelmann. 2003. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol 23:1674-1687.

Stoica, G. E., T. F. Franke, M. Moroni, S. Mueller, E. Morgan, M. C. Iann, A. D. Winder, R. Reiter, A. Wellstein, M. B. Martin, and A. Stoica. 2003. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:7998-8011.

Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, Hayes DF, Desta Z, Flockhart DA. 2003. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 95(23):1758-1764.

Tilli MT, Frech MS, Steed ME, Hruska KS, Johnson MD, Flaws JA, Furth PA. 2003. Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol 163(5):1713-1719.

Tirado OM, Mateo-Lozano S, Sanders S, Dettin LE, Notario V. 2003. The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation. Cancer Res 63(19):6290-6298.

Tsai, M. S., L. A. Shamon-Taylor, I. Mehmi, and C. K. Tang. 2003. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 22:761-768.

Uren, A., M. S. Merchant, C. J. Sun, M. I. Vitolo, Y. Sun, M. Tsokos, P. B. Illei, M. Ladanyi, A. Passaniti, C. Mackall, and J. A. Toretsky. 2003. Beta-plateletderived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene 22:2342.

Veldman, T., X. Liu, H. Yuan, and R. Schlegel. 2003. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc.Natl.Acad.Sci.U.S.A. 100:8211-8216.

Xie, Z., X. Zeng, T. Waldman, and R. I. Glazer. 2003. Transformation of mammary Epithelial Cells by 3-Phosphoinositide-dependent Protein Kinase-l (PDKl) Activates 13-Catenin and c-myc and Downregulates Caveolin-l. Cancer Res. 63:5370-5375.

Xiong, J., S. Fan, Q. Meng, L. Schramm, C. Wang, B. Bouzahza, J. Zhou, B. Zafonte, I. D. Goldberg, B. R. Haddad, R. G. Pestell, and E. M. Rosen. 2003. BRCA1 inhibition of telomerase activity in cultured cells. Mol.Cell Biol 23:8668-8690.

Xu, J., L. Lecanu, Z. Han, Z. Yao, J. Greeson, and V. Papadopoulos. 2003. Inhibition of adrenal cortical steroid formation by procaine is mediated by reduction of the cAMP-induced 3-hydroxy-3-methylglutaryl-coenzyme A reductase messenger ribonucleic acid levels. J.Pharmacol.Exp.Ther. 307:1148-1157.

Zhang, M., H. Liu, R. Guo, Y. Ling, X. Wu, B. Li, P. P. Roller, S. Wang, and D. Yang. 2003. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem.Pharmacol. 66:93-103.